<DOC>
	<DOCNO>NCT01148277</DOCNO>
	<brief_summary>This prospective , randomized-controlled trial ( RCT ) compare use Propofol Remifentanyl traditional sedation ( Midazolam Fentanyl ) diagnostic colonoscopy patient compensate cirrhosis child A-B . The work hypothesis use propofol translate short recovery discharge time higher patient satisfaction decrease general complication ( Hepatic Encephalopathy ) context patient advance liver disease .</brief_summary>
	<brief_title>Propofol Remifentanyl Versus Midazolam Fentanyl Diagnostic Colonoscopy Patients With Compensated Cirrhosis Child A-B</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Consecutive patient older 18 young 75 year cirrhosis define presence liver fibrosis least F3 high METAVIR score establish cirrhosis ( Child Pugh A , B ) Patients significant cardiorespiratory disease i.e . advanced respiratory , renal heart failure ( ASA class III high except patient decompensate liver cirrhosis ) , obstructive sleep apnea . HCC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Endoscopies</keyword>
	<keyword>Liver disease</keyword>
	<keyword>Propofol</keyword>
	<keyword>Midazolam remifentanyl</keyword>
</DOC>